Freeline Presents Positive New Data from Phase 1/2 Trial of FLT201, Its Novel Gene Therapy Candidate for Gaucher Disease, in Late-Breaking Oral Presentation at ASGCT 27th Annual Meeting
Plugin JSON Content Importer Pro not running: Check Licence! Check that a Licence is active for https://freeline.life